Breaking News
September 25, 2018 - Study provides evidence of beta lactamase producing, antimicrobial resistant E. coli in U.S. retail meat
September 25, 2018 - UCI study finds new cause of cerebral microbleeds
September 25, 2018 - Researchers propose mechanism by which ASTN2 protein defects lead to brain disorders
September 25, 2018 - Chinese and German researchers to cooperate more closely in future for better food
September 25, 2018 - Recent study helps predict probability of pregnant mothers to have child with autism
September 25, 2018 - New online, sound matching tool offers tinnitus sufferers potential treatment options
September 25, 2018 - UC Davis researchers take critical step in developing more effective Salmonella vaccine
September 25, 2018 - Antibiotics best paediatric treatment for children’s chronic wet cough
September 25, 2018 - Looking beyond opioids: Stanford pain psychologist briefs Congress
September 25, 2018 - Organs actively fighting back against autoimmune diseases, finds study
September 25, 2018 - Lancaster professor aims to understand how genes affect smoking cessation
September 25, 2018 - Human-oriented perspective needed to better understand Parkinson’s disease
September 25, 2018 - Physical activity may have beneficial effects for people with rare Alzheimer’s disease
September 25, 2018 - FDA Updates on Valsartan Recalls
September 25, 2018 - 3-D-printed tracheal splints used in groundbreaking pediatric surgery
September 25, 2018 - Who is the designated driver, or proxy, for your health decisions?
September 25, 2018 - New chemo-optogenetic method enables multi-directional activity control of cellular processes
September 25, 2018 - Study explores link between genetic predisposition to Alzheimer’s and cardiometabolic risk factors
September 25, 2018 - NeoTract presents new clinical data from studies of UroLift System for patients with BPH
September 25, 2018 - Statins Improve Long-Term Survival After AAA Repair
September 25, 2018 - Novel brain network linked to chronic pain in Parkinson’s disease
September 25, 2018 - Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear
September 25, 2018 - Older adults with ‘fall plan of care’ less likely to suffer fall-related hospitalizations
September 25, 2018 - FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials
September 25, 2018 - IME Medical Electrospinning establishes state-of-the-art manufacturing lab facilities
September 25, 2018 - Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results
September 25, 2018 - How to Protect Your Eyesight
September 25, 2018 - Novel approach allows researchers to define how cells in the retina respond to diabetes
September 25, 2018 - Columbia University announces winners of 2018 Louisa Gross Horwitz Prize
September 25, 2018 - Clinical trial investigators found non-compliant with requirement to report results on EU register
September 25, 2018 - Study analyzes quality of protein supplements in function of source, treatment and storage
September 25, 2018 - FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome
September 25, 2018 - U.S. Alzheimer’s Cases to Nearly Triple by 2060
September 25, 2018 - Improving cell replacement therapy for Parkinson’s disease
September 25, 2018 - Genervon reports new findings that drug candidate GM6 attenuates Alzheimer’s disease in mice model
September 25, 2018 - FDA approves new 5 mm diameter drug-eluting stent from Cook Medical
September 25, 2018 - New $17.8 million grant ensures USC at forefront of research on tobacco-related health risks
September 25, 2018 - Researchers analyze response to combination immunotherapy for patients with rare skin cancer
September 25, 2018 - Study sheds light on how brain protein may be involved neurodevelopmental disorders
September 25, 2018 - Where to draw the line on incentives
September 25, 2018 - Solid fuel use linked with increased risk of hospitalization or death from respiratory diseases
September 25, 2018 - ‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms
September 25, 2018 - Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE
September 25, 2018 - Global leaders must make bold commitments at first-ever UN tuberculosis summit
September 25, 2018 - Brief sleep intervention works long-term to prevent child obesity
September 25, 2018 - Vaping among kids and teens a growing concern
September 25, 2018 - Public launch of products and application solutions from Porvair Laboratory Division
September 25, 2018 - Harmful H. pylori may play a role in Parkinson’s disease
September 25, 2018 - Researchers develop way to measure different types of fear of falling in patients with Parkinson’s
September 25, 2018 - Fracture causes bone density losses throughout the body
September 25, 2018 - Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder
September 25, 2018 - Hybrid theranostic complex shows high therapeutic efficacy against tumor cells
September 25, 2018 - FDA Issues Statement Reaffirming the Positive Benefit-Risk Profile of Nuplazid (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
September 25, 2018 - Toxicological evaluation and dosimetry estimation of potential PET radiotracer
September 25, 2018 - 5 obstacles parents commonly face in child obesity treatment and how to overcome them
September 25, 2018 - Immunologist to study how Chikungunya causes devastating effects in older adults
September 25, 2018 - Rural borderland communities vulnerable to high stress impacting mental and physical health
September 25, 2018 - SNMMI announces recipients of 2018-2020 Wagner-Torizuka Fellowship
September 25, 2018 - Common painkiller not effective in controlling chronic pain after traumatic nerve injury
September 25, 2018 - New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer
September 25, 2018 - Environmentally-induced gene activity influences IQ test performance
September 25, 2018 - Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI
September 25, 2018 - FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
September 25, 2018 - Medical device company settles US case over false claims
September 25, 2018 - Trying to get answers: One woman’s quest for a diagnosis
September 25, 2018 - Lung cancer patients treated with invasive surgery more likely to become chronic opioid users
September 25, 2018 - Oxford VR raises £3.2m to boost innovation in VR for mental health problems
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
September 25, 2018 - Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked
September 25, 2018 - FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial
September 25, 2018 - New program to reduce harmful stress effectively improves mood in cancer patients
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
Fruit fly research leads to potential drug for debilitating diseases caused by parasitic worms

Fruit fly research leads to potential drug for debilitating diseases caused by parasitic worms

image_pdfDownload PDFimage_print

River blindness and elephantiasis are debilitating diseases caused by parasitic worms that infect as many as 150 million people worldwide. They are among the “neglected tropical diseases” for which better treatments are desperately needed. But they were far from the mind of cell biologist William Sullivan when he began studying the microbial parasite Wolbachia, best known for its extraordinary effects on the many insect species it infects.

Sullivan, a professor of molecular, cell, and developmental biology at UC Santa Cruz, has spent much of his career studying the basic biology of the cell cycle in the fruit fly Drosophila. To study the interactions of Wolbachia with its insect hosts, he created a stable cell line of Wolbachia-infected Drosophila cells which he could grow indefinitely in the laboratory. This cell line turned out to be an invaluable tool for researchers seeking new drugs to treat river blindness and related diseases.

That’s because the filarial nematodes that cause these diseases are actually dependent on Wolbachia living within their cells. Kill the Wolbachia, and the worms die.

“The insects would rather not have the Wolbachia infection–it manipulates their reproductive biology and does all these things to promote its own survival. But the worms can’t live without it,” Sullivan said.

Sullivan’s lab worked with the UC Santa Cruz Chemical Screening Center to develop an automated screening assay that could be used to test thousands of compounds for the ability to kill Wolbachia without harming the Drosophila host cells. Sullivan’s team screened nearly 5,000 compounds, of which 40 were active against Wolbachia, including several related to a compound (albendazole) already used to treat filarial nematode infections. Their findings, published in 2012, showed that albendazole and its metabolites target both the worms and the Wolbachia.

Albendazole and other existing treatments all have shortcomings, however, and Sullivan soon realized that he did not have the funding or the resources to pursue the search for better treatments any further. “At that point, we were stuck, because we didn’t have the resources for a full-scale drug discovery effort,” he said.

Then he found out about the California Institute for Biomedical Research (Calibr), a nonprofit organization dedicated to developing medicines for unmet medical needs. With funding from the Bill & Melinda Gates Foundation, Calibr works with external partners, including academic researchers, and provides drug discovery expertise and infrastructure.

Sullivan ended up giving a seminar on his Wolbachia work at Calibr’s facilities in La Jolla, which led to an ongoing collaboration. One of his graduate students, Pamela White, worked with Calibr scientists to train them on the screening assay. Ultimately, Calibr tested more than 300,000 compounds with an optimized version of the assay for high-throughput screening.

Sullivan’s lab also helped develop a secondary assay for assessing the effectiveness of promising compounds against Wolbachia in filarial nematodes. That was important because the Wolbachia species that infect Drosophila are significantly different from those that infect the worms. “The cell-based assay is not a perfect assay, but it gives you a starting point,” he said.

Using Sullivan’s assays, Calibr has identified a lead compound, improved its performance, and tested it in animals infected with filarial worms. The compound is currently in preclinical development, the stage at which scientists assess safety and tolerability in animal models. If all goes well, the next step will be phase I clinical trials in humans.

“It’s a good example of why we do basic research. You never know where it will lead,” Sullivan said.

He admits that transferring his assays to Calibr felt a little uncomfortable at first. “At the time, I thought of it as my thing. But now that I see what they’ve done with it, I’ve realized that our contribution was part of a much larger effort and this handoff happened at the perfect time,” Sullivan said.

A drug that targets Wolbachia has several advantages over one that targets the worms directly. Research over the past decade has shown that much of the harm caused by filarial nematode infections results from the immune system’s inflammatory response to Wolbachia released by the worms. Eliminating the Wolbachia before the worms die reduces that harmful immune response and leads to a slow death of the worms.

The antibiotic doxycycline has been tested in clinical trials and shown to be an effective treatment for elephantiasis (lymphatic filariasis) when given in daily doses for at least four weeks. But a more potent drug with a shorter course of treatment would be much more practical for use in the developing countries where these diseases are prevalent, Sullivan said.

Meanwhile, Sullivan has begun teaching a course on neglected tropical diseases at UC Santa Cruz. He said the students are amazed to learn how common these diseases are compared to how much research is done on them. “One in six people on this planet suffer from a disease that most people in this country have never heard of,” he said. “It’s been really eye-opening, for me and for the students.”

Sullivan’s lab has also continued to study Wolbachia infections in Drosophila, returning to the project for which the infected cell line was initially created. Using the same automated screening assay used in the drug discovery project, Sullivan’s team screened the Drosophila genome to find genes that either suppress or increase the proliferation of Wolbachia in host cells. The study, published in 2017, identified several key biological pathways that Wolbachia alters in host cells to maintain infections. The findings may explain why Wolbachia infection makes insects resistant to RNA viruses, a feature that is now being exploited in efforts to combat the spread of Zika, dengue, and other mosquito-transmitted diseases.

“There are so many amazing Wolbachia stories, and we still have a lot to learn about it,” Sullivan said.​

Source:

https://news.ucsc.edu/2018/07/river-blindness.html

Tagged with:

About author

Related Articles